Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 40,000 shares at $68.49 ($2.7M) on 2020-04-23, disclosed to the SEC on 2020-04-24.
Seasonal sale ($2.7M) by Chairman — this insider has traded EBS in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.81 | 20,000 | $1.3M | 49.4% |
| 2 | $68.49 | 20,000 | $1.4M | 50.6% |
| Total | $67.65 avg | 40,000 | $2.7M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |